Price (90d)
$398.42Signal Score (90d)
110Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $10.06B | $2.86B | $8.00 |
| 2024 | $8.35B | $2.32B | $6.54 |
| 2023 | $7.12B | $1.80B | $5.12 |
| 2022 | $6.22B | $1.32B | $3.72 |
| 2021 | $5.71B | $1.70B | $4.79 |
Social Signal Score
Earnings
Tue, Oct 20(in 2 months)
Consensus estimate $2.61 per share
Typical surprise +12.9% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 16$2.80 vs $2.48beat
- Tue, Apr 21$2.80 vs $2.51beat
- Thu, Jan 22$2.53 vs $2.27beat
- Tue, Oct 21$2.40 vs $1.99beat
- Tue, Jul 22$2.19 vs $1.93beat
- Tue, Apr 22$1.81 vs $1.74beat
Estimates and results for ISRG via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from ISRG's reported EPS growth of 13.7% a year over 4 years.
- EPS in 5 years
- $15.21
- Implied price
- $273.71
- Return from $394.51
- -7.1% a year
To earn 15.0% a year on these assumptions you'd need to buy at $136.08 — -65.5% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| 3.7% | -21.8% | -18.3% | -15.2% | -12.6% | -10.2% |
| 8.7% | -18.1% | -14.3% | -11.1% | -8.4% | -5.9% |
| 13.7% | -14.3% | -10.4% | -7.1% | -4.1% | -1.5% |
| 18.7% | -10.5% | -6.4% | -3.0% | 0.1% | 2.8% |
| 23.7% | -6.8% | -2.5% | 1.1% | 4.3% | 7.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (9)
- Newszacks.com·3d ago·Positive
ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern? ISRG's US procedure growth slows in Q2, but ACA-related care deferrals may prove temporary as underlying demand and da Vinci 5 adoption remain strong.
View source ↗ - News (RSS)seekingalpha·3d ago·Neutral
Intuitive Surgical: Priced For Precision
View source ↗ - News247wallst.com·4d ago·Neutral
The Number One Reason I Keep Buying Intuitive Surgical Now For The Long Run I keep hitting the buy button on Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction), and the recent drawdown has only made me press it harder.
View source ↗ - News (RSS)yahoo·4d ago·Positive
Intuitive Surgical (ISRG) Just Beat Earnings. Is the Stock Still Worth Paying a Premium?
View source ↗ - News (RSS)yahoo·5d ago·Neutral
Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?
View source ↗ - Newszacks.com·5d ago·Neutral
ISRG Trades at a Premium P/E: Buy, Sell or Hold the Stock Now? ISRG's premium valuation faces scrutiny as strong Q2 growth, higher margins and expanding robotic platforms support its 2026 outlook.
View source ↗ - News (Marketaux)finance.yahoo.com·6d ago·Positive
Competition Is Heating Up, but Here's Why Intuitive Surgical Might Still Be the Smartest Bet in MedTech Intuitive Surgical (<e[+299 characters]
View source ↗ - Newsfool.com·7d ago·Neutral
Competition Is Heating Up, but Here's Why Intuitive Surgical Might Still Be the Smartest Bet in MedTech Intuitive Surgical makes the da Vinci surgical robot, with 11,710 systems in use globally. Medical device competitors Medtronic and Johnson & Johnson are bringing out their own surgical robots.
View source ↗ - News247wallst.com·7d ago·Neutral
The Robotic Surgery Leader: Intuitive Surgical Slides Further But One Wall Street Bull Pegs Returns at 85% Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction) trades at $373.71, while the average Wall Street price target sits at $477.25.
View source ↗